Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomised trial

M. Groenvold, Peter Fayers, M. A. A. Peterson, H. T. Mouridsen

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences